Meridian Bioscience ROE 2006-2019 | VIVO

Current and historical return on equity (ROE) values for Meridian Bioscience (VIVO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Meridian Bioscience ROE for the three months ending September 30, 2019 was 15.72%.
Meridian Bioscience ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $0.02B $0.19B 12.96%
2019-06-30 $0.03B $0.19B 13.79%
2019-03-31 $0.03B $0.18B 15.19%
2018-12-31 $0.03B $0.18B 14.22%
2018-09-30 $0.02B $0.18B 13.20%
2018-06-30 $0.02B $0.18B 13.87%
2018-03-31 $0.02B $0.17B 9.93%
2017-12-31 $0.02B $0.17B 12.32%
2017-09-30 $0.02B $0.17B 12.44%
2017-06-30 $0.02B $0.17B 11.92%
2017-03-31 $0.03B $0.17B 17.26%
2016-12-31 $0.03B $0.17B 17.29%
2016-09-30 $0.03B $0.17B 18.99%
2016-06-30 $0.04B $0.17B 20.77%
2016-03-31 $0.04B $0.17B 20.93%
2015-12-31 $0.04B $0.17B 21.82%
2015-09-30 $0.04B $0.17B 21.47%
2015-06-30 $0.04B $0.16B 21.64%
2015-03-31 $0.04B $0.16B 21.71%
2014-12-31 $0.04B $0.16B 21.74%
2014-09-30 $0.03B $0.16B 21.25%
2014-06-30 $0.04B $0.16B 22.08%
2014-03-31 $0.04B $0.16B 23.11%
2013-12-31 $0.04B $0.16B 23.57%
2013-09-30 $0.04B $0.16B 25.00%
2013-06-30 $0.04B $0.15B 25.52%
2013-03-31 $0.04B $0.15B 25.26%
2012-12-31 $0.04B $0.14B 25.58%
2012-09-30 $0.04B $0.14B 24.87%
2012-06-30 $0.03B $0.14B 23.61%
2012-03-31 $0.03B $0.14B 22.30%
2011-12-31 $0.03B $0.14B 20.25%
2011-09-30 $0.03B $0.14B 19.57%
2011-06-30 $0.03B $0.14B 18.18%
2011-03-31 $0.02B $0.14B 17.49%
2010-12-31 $0.02B $0.14B 16.73%
2010-09-30 $0.03B $0.14B 18.81%
2010-06-30 $0.03B $0.14B 21.66%
2010-03-31 $0.03B $0.14B 23.91%
2009-12-31 $0.03B $0.14B 24.95%
2009-09-30 $0.03B $0.14B 24.63%
2009-06-30 $0.03B $0.14B 24.33%
2009-03-31 $0.03B $0.13B 24.08%
2008-12-31 $0.03B $0.13B 24.55%
2008-09-30 $0.03B $0.13B 24.44%
2008-06-30 $0.03B $0.12B 23.53%
2008-03-31 $0.03B $0.12B 25.16%
2007-12-31 $0.03B $0.12B 25.34%
2007-09-30 $0.03B $0.11B 25.53%
2007-06-30 $0.03B $0.11B 25.74%
2007-03-31 $0.02B $0.10B 22.74%
2006-12-31 $0.02B $0.10B 22.52%
2006-09-30 $0.02B $0.09B 20.99%
2006-06-30 $0.02B $0.09B 20.45%
2006-03-31 $0.02B $0.09B 20.71%
2005-12-31 $0.01B $0.09B 21.13%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.419B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $162.450B 28.35
Medtronic (MDT) Ireland $162.306B 22.42
Stryker (SYK) United States $81.207B 27.30
Boston Scientific (BSX) United States $61.398B 28.98
Baxter (BAX) United States $46.542B 28.22
Essilor Luxottica (ESLOY) France $33.935B 0.00
Zimmer Biomet Holdings (ZBH) United States $31.054B 19.48
Lonza Group Ag (LZAGY) Switzerland $30.726B 0.00
Terumo (TRUMY) Japan $27.631B 34.48
Coloplast (CLPBY) Denmark $27.475B 42.40
ResMed (RMD) United States $23.636B 43.60
Smith & Nephew SNATS (SNN) United Kingdom $21.789B 0.00
Sunny Optical Technology (SNPTF) China $20.017B 0.00
Insulet (PODD) United States $11.820B 562.35
Bio-Rad Laboratories (BIO) United States $11.331B 54.38
Canopy Growth (CGC) Canada $8.412B 0.00
Perrigo (PRGO) Ireland $8.096B 15.10
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.608B 22.37
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.859B 39.59
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.053B 31.92
ICU Medical (ICUI) United States $4.016B 26.18
Neogen (NEOG) United States $3.682B 61.28
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.427B 0.00
Agios Pharmaceuticals (AGIO) United States $3.169B 0.00
Quidel (QDEL) United States $3.142B 29.82
National Vision Holdings (EYE) United States $2.772B 62.57
Aurora Cannabis (ACB) Canada $2.223B 0.00
Cardiovascular Systems (CSII) United States $1.893B 0.00
AtriCure (ATRC) United States $1.510B 0.00
InMode (INMD) Israel $1.476B 0.00
Aphria (APHA) $1.443B 0.00
TG Therapeutics (TGTX) United States $1.341B 0.00
VAREX IMAGING (VREX) United States $1.194B 23.86
NanoString Technologies (NSTG) United States $1.061B 0.00
Phibro Animal Health (PAHC) United States $1.035B 19.38
PetIQ (PETQ) United States $0.857B 20.90
Eagle Pharmaceuticals (EGRX) United States $0.792B 30.32
Lantheus Holdings (LNTH) United States $0.736B 18.39
LeMaitre Vascular (LMAT) United States $0.736B 41.36
Quanterix (QTRX) United States $0.710B 0.00
Omeros (OMER) United States $0.672B 0.00
Cerus (CERS) United States $0.603B 0.00
MacroGenics (MGNX) United States $0.575B 0.00
Surmodics (SRDX) United States $0.563B 58.31
OraSure Technologies (OSUR) United States $0.504B 30.26
Organigram Holdings (OGI) Canada $0.477B 0.00
Owens & Minor (OMI) United States $0.423B 15.65
HEXO (HEXO) $0.389B 0.00
Utah Medical Products (UTMD) United States $0.388B 28.14
Zynex (ZYXI) United States $0.348B 39.37
BioLife Solutions (BLFS) United States $0.311B 126.67
Female Health (VERU) United States $0.297B 0.00
Bovie Medical (APYX) United States $0.283B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.282B 0.00
Repro-Med Systems (KRMD) United States $0.250B 0.00
Vapotherm (VAPO) United States $0.246B 0.00
United Health Products (UEEC) United States $0.229B 0.00
Viemed Healthcare (VMD) United States $0.213B 22.40
Liberty Health Sciences (LHSIF) Canada $0.180B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.175B 0.00
InfuSystems Holdings (INFU) United States $0.173B 874.00
Rockwell Medical (RMTI) United States $0.168B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.134B 9.48
Chimerix (CMRX) United States $0.123B 0.00
Surface Oncology (SURF) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
MTech Acquisition (KERN) United States $0.093B 0.00
United-Guardian (UG) United States $0.083B 21.10
MRI Interventions (MRIC) United States $0.079B 0.00
Nephros (NEPH) United States $0.076B 0.00
Chembio Diagnostics (CEMI) United States $0.068B 0.00
FSD PHARMA INC (HUGE) $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
NF Energy Saving (BIMI) China $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00